DOES YOUR CHILD SUFFER FROM MIGRAINES?
Accellacare is offering a research opportunity for children and adolescents diagnosed with migraine. This research study is evaluating the safety and efficacy of an investigational drug for the acute treatment of migraine in children and teens.
The study may be an option for your child if they:
Are aged between 6 to 17 years old.
Have had a history of migraine with or without aura consistent with a diagnosis for at least 6 months.
Have migraines that typically last between 3 and 72 hours if treated or untreated unsuccessfully, with migraine episodes occurring at least 48 hours apart.
Have a history of 1 to 14 migraine attacks per month with moderate to severe headaches.
Are currently using or have previously used at least 1 oral medication (over-the-counter medication or prescription medication) for the acute treatment of migraine.
Other criteria apply.
Qualified participants may receive the study drug and will receive study-related evaluations and care at no cost. Financial compensation will also be provided for time and travel expenses.
Visit our website for more info: https://www.accellacare.us/join-a-study/migraines/childhood-migraines